The effects of N-acetyl-cysteine and acetyl-l-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury

Neuroscience

Volumn 269, Issue , 2014, Pages 143-151

  Karalija, A ^a   Novikova, L N ^a   Kingham, P J ^a   Wiberg, M ^a   Novikov, L N ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Adult rats; Antioxidants; Apoptosis; Motoneurons; Spinal cord

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CELL PROTEIN; ECTODYSPLASIN A; LEVACECARNINE; OX42 PROTEIN; PROTEIN BAX; SEROTONIN; UNCLASSIFIED DRUG; ACETYLCARNITINE; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL LOSS; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; NERVE SPROUTING; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RUBROSPINAL TRACT; SIGNAL TRANSDUCTION; SPINE INJURY; ANIMAL; CERVICAL SPINE; DISEASE MODEL; DRUG EFFECTS; IMMUNOMODULATION; MICROGLIA; MOTONEURON; NERVE FIBER; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPINAL CORD; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT;

ACETYLCARNITINE; ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; AXONS; CELL SURVIVAL; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; FEMALE; MICROGLIA; MOTOR NEURONS; NERVE REGENERATION; NEUROIMMUNOMODULATION; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84898821070     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.03.042     Document Type: Article

References (54)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
2. Atkuri K.R., Mantovani J.J., Herzenberg L.A., Herzenberg L.A. N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007, 7:355-359.
3. Bains M., Hall E.D. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012, 1822:675-684.
4. Benowitz L.I., Popovich P.G. Inflammation and axon regeneration. Curr Opin Neurol 2011, 24:577-583.
5. Bydon M., Lin J., Macki M., Gokalsan Z.L., Bydon A. The role of steroids in acute spinal cord injury. World Neurosurg 2013, 11:12.
6. Charriaut-Marlangue C. Apoptosis: a target for neuroprotection. Therapie 2004, 59:185-190.
7. Circu M.L., Aw T.Y. Glutathione and apoptosis. Free Radic Res 2008, 42:689-706.
8. Deumens R., Koopmans G.C., Joosten E.A. Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol 2005, 77:57-89.
9. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388.
10. Fan L., Wang K., Cheng B. Effects of buyang huanwu decoction on apoptosis of nervous cells and expressions of Bcl-2 and bax in the spinal cord of ischemia-reperfusion injury in rabbits. J Tradit Chin Med 2006, 26:153-156.
11. Farr S.A., Poon H.F., Dogrukol-Ak D., Drake J., Banks W.A., Eyerman E., Butterfield D.A., Morley J.E. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003, 84:1173-1183.
12. Hagberg H. Mitochondrial impairment in the developing brain after hypoxia-ischemia. J Bioenerg Biomembr 2004, 36:369-373.
13. Hall E.D., Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004, 1:80-100.
14. Hart A.M., Wiberg M., Youle M., Terenghi G. Systemic acetyl-l-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp Brain Res 2002, 145:182-189.
15. Heard K.J. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008, 359:285-292.
16. Hou Q., Cymbalyuk E., Hsu S.C., Xu M., Hsu Y.T. Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome C release and Bax regulation. Apoptosis 2003, 8:617-629.
17. Jia Z., Zhu H., Li J., Wang X., Misra H., Li Y. Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal cord 2012, 50:264-274.
18. Karalija A., Novikova L.N., Kingham P.J., Wiberg M., Novikov L.N. Neuroprotective effects of N-acetyl-cysteine and acetyl-l-carnitine after spinal cord injury in adult rats. PLoS One 2012, 7:e41086.
19. Karimi-Abdolrezaee S., Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol 2012, 46:251-264.
20. Kullberg S., Aldskogius H., Ulfhake B. Microglial activation, emergence of ED1-expressing cells and clusterin upregulation in the aging rat CNS, with special reference to the spinal cord. Brain Res 2001, 899:169-186.
21. Kwon B.K., Liu J., Messerer C., Kobayashi N.R., McGraw J., Oschipok L., Tetzlaff W. Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci U S A 2002, 99:3246-3251.
22. Ma J., Novikov L.N., Wiberg M., Kellerth J.O. Delayed loss of spinal motoneurons after peripheral nerve injury in adult rats: a quantitative morphological study. Exp Brain Res 2001, 139:216-223.
23. Malaguarnera M. Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol 2012, 28:166-176.
24. Maragos W.F., Korde A.S. Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury. J Neurochem 2004, 91:257-262.
25. McEwen M.L., Sullivan P.G., Rabchevsky A.G., Springer J.E. Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics 2011, 8:168-179.
26. Novikov L., Novikova L., Kellerth J.-O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience 1997, 79:765-774.
27. Novikov L.N., Novikova L.N., Mosahebi A., Wiberg M., Terenghi G., Kellerth J.O. A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury. Biomaterials 2002, 23:3369-3376.
28. Novikova L.N., Novikov L.N., Kellerth J.O. Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci 2000, 12:776-780.
29. Palacio J.R., Markert U.R., Martinez P. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflamm Res 2011, 60:695-704.
30. Parnetti L., Gaiti A., Mecocci P., Cadini D., Senin U. Pharmacokinetics of IV and oral acetyl-l-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type. Eur J Clin Pharmacol 1992, 42:89-93.
31. Patel S.P., Sullivan P.G., Lyttle T.S., Rabchevsky A.G. Acetyl-l-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem 2010, 114:291-301.
32. Patel S.P., Sullivan P.G., Lyttle T.S., Magnuson D.S., Rabchevsky A.G. Acetyl-l-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. Neuroscience 2012, 210:296-307.
33. Paxinos G. The rat nervous system 1995, Academic Press, San Diego.
34. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999, 6:99-104.
35. Priestley J.V., Michael-Titus A.T., Tetzlaff W. Limiting spinal cord injury by pharmacological intervention. Handb Clin Neurol 2012, 109:463-484.
36. Rabchevsky A.G., Patel S.P., Springer J.E. Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?. Pharmacol Ther 2011, 132:15-29.
37. Ribas G.S., Vargas C.R., Wajner M. l-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 2014, 533:469-476.
38. Rudel T. Caspase inhibitors in prevention of apoptosis. Herz 1999, 24:236-241.
39. Sadowska A.M. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther Adv Respir Dis 2012, 6:127-135.
40. Santos R.O., Malvar B., Silva R., Ramalho V., Pessegueiro P., Amoedo M., Aniceto J., Pires C. Contrast-induced nephropathy. Acta Med Port 2011, 24:809-820.
41. Sayer F.T., Kronvall E., Nilsson O.G. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 2006, 6:335-343.
42. Short D.J., El Masry W.S., Jones P.W. High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal cord 2000, 38:273-286.
43. Silva N.A., Sousa N., Reis R.L., Salgado A.J. From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol 2014, 114C:25-57.
44. Snigdha S., Smith E.D., Prieto G.A., Cotman C.W. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 2012, 28:14-24.
45. Song Y., Zeng Z., Jin C., Zhang J., Ding B., Zhang F. Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the JAK/STAT signaling pathway. Neurochem Res 2012, 610-619.
46. Springer J.E., Nottingham S.A., McEwen M.L., Azbill R.D., Jin Y. Caspase-3 apoptotic signaling following injury to the central nervous system. Clin Chem Lab Med 2001, 39:299-307.
47. Vukojevic K., Carev D., Sapunar D., Petrovic D., Saraga-Babic M. Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. J Mol Histol 2008, 39:339-349.
48. Waring W.S. Criteria for acetylcysteine treatment and clinical outcomes after paracetamol poisoning. Expert Rev Clin Pharmacol 2012, 5:311-318.
49. Welin D., Novikova L.N., Wiberg M., Kellerth J.O., Novikov L.N. Effects of N-acetyl-cysteine on the survival and regeneration of sural sensory neurons in adult rats. Brain Res 2009, 1287:58-66.
50. Wilson A.D., Hart A., Brannstrom T., Wiberg M., Terenghi G. Delayed acetyl-l-carnitine administration and its effect on sensory neuronal rescue after peripheral nerve injury. J Plast Reconstr Aesthet Surg 2007, 60:114-118.
51. Yin X., Yin Y., Cao F.L., Chen Y.F., Peng Y., Hou W.G., Sun S.K., Luo Z.J. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 2012, 7:e38381.
52. Zhang C.G., Welin D., Novikov L., Kellerth J.O., Wiberg M., Hart A.M. Motorneuron protection by N-acetyl-cysteine after ventral root avulsion and ventral rhizotomy. Br J Plast Surg 2005, 58:765-773.
53. Zhang N., Yin Y., Xu S.J., Wu Y.P., Chen W.S. Inflammation and apoptosis in spinal cord injury. Indian J Med Res 2012, 135:287-296.
54. Ziment I. Acetylcysteine: a drug that is much more than a mucokinetic. Biomed Pharmacother 1988, 42:513-519.